Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Halma plc (HLMA.L)
GBp3,614.00
+20.00 (+0.56%)
GB LSE Industrials Conglomerates
Address
Misbourne Court HP7 0DE
Amersham, BU, GB
Amersham, BU, GB
CEO
Marc Arthur Ronchetti
Website
halma.com
IPO
1988-07-01
ISIN GB0004052071
Also trades on
London Stock Exchange · HLMA.L (GBp)
Other OTC · HALMY (USD)
Other OTC · HLMAF (USD)
Description
Halma plc, a company established in 1894 and headquartered in Amersham, United Kingdom, specializes in delivering innovative technological solutions across critical safety, health, and environmental sectors. Its operations are organized into three distinct divisions: Safety, Environmental & Analysis, and Medical. The Safety division offers a range of protective technologies, encompassing fire detection and advanced suppression systems, safety mechanisms for elevators, security sensors, and systems for managing pedestrian and vehicle movement. It also develops specialized interlocks for secure process control, as well as solutions for explosion prevention and corrosion oversight. These offerings cater to various applications, including elevator safety, fire management, crowd and traffic flow, industrial access, and secure storage solutions. Focused on monitoring and analysis, the Environmental & Analysis segment provides advanced optical, optoelectronic, and spectral imaging solutions. It also develops instruments for tracking water, air, and gas quality, including devices to detect hazardous gases and assess overall air purity, alongside comprehensive water analysis and treatment systems. Its expertise serves fields such as optical diagnostics, water management, gas detection, and broad environmental monitoring. The Medical division is dedicated to healthcare innovations, supplying essential fluidic components for medical diagnostics and original equipment manufacturers. It also produces laboratory instruments and platforms designed to provide crucial insights into patient health, aiding providers in clinical decision-making. Furthermore, the segment develops specialized technologies and approaches to facilitate in-vitro diagnostics, scientific discoveries, and product development in life sciences, ensuring beneficial outcomes across diverse medical specialties.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
GBp3,614.00
+20.00 (+0.56%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
0.98
Float Shares
373.19M
Free Float %
98.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.76% | -14.85% | -14.52% | +0.52% | +12.27% | +10.18% | +25.26% | +58.97% | +39.66% | +317.12% | +6,899.46% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
3,614.00
DCF (Unlevered)
3,297.17
-8.8%
DCF (Levered)
3,675.53
+1.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
44% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 6 | 0 |
| Hold | 8 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 1 | 0 |
Quality scores
Altman Z-Score
8.63
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Conglomerates: +6.1%+14.9% ★ Q1'26: +24.1% (vs Q1'24)
-
EPS growth Conglomerates: +16.9%+25.6% ★ Q1'26: +22.5% (vs Q1'24)
-
FCF margin FCF growth · Conglomerates: +35.9%+14.2% Q1'26: +18.4% (vs Q1'24)
-
EBIT margin Conglomerates: +9.0%+20.4% ★ Q1'26: +20.0% (vs Q1'24)
-
ROIC Conglomerates: +4.7%+13.6% ★ Q1'26: +27.3% (vs Q1'24)
-
Share dilution Conglomerates: +0.0%+0.0% Q1'26: +0.2% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×1.39× ★ Q1'26: 0.67× (vs Q1'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 1996 actual |
Mar 1997 actual |
Mar 1998 actual |
Mar 1999 actual |
Mar 2000 actual |
Mar 2001 actual |
Mar 2002 actual |
Mar 2003 actual |
Mar 2004 actual |
Mar 2005 actual |
Mar 2006 actual |
Mar 2007 actual |
Mar 2008 actual |
Mar 2009 actual |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 14 Rev. Ana. 11 EPS Ana. |
Mar 2027 14 Rev. Ana. 11 EPS Ana. |
Mar 2028 14 Rev. Ana. 7 EPS Ana. |
Mar 2029 7 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
173.65M
est: 178.64M (-2.8%)
|
200.14M
est: 205.44M (-2.6%)
|
213.78M
est: 227.02M (-5.8%)
|
217.76M
est: 176.20M (+23.6%)
|
233.49M
est: 233.31M (+0.1%)
|
268.32M
est: 262.67M (+2.2%)
|
267.60M
est: 278.63M (-4.0%)
|
267.29M
est: 272.91M (-2.1%)
|
292.64M
est: 301.76M (-3.0%)
|
268.72M
est: 298.43M (-10.0%)
|
310.77M
est: 332.69M (-6.6%)
|
351.12M
est: 359.69M (-2.4%)
|
395.06M
est: 402.84M (-1.9%)
|
455.93M
est: 464.71M (-1.9%)
|
459.12M
est: 460.75M (-0.4%)
|
518.43M
est: 519.67M (-0.2%)
|
579.88M
est: 590.63M (-1.8%)
|
619.21M
est: 634.58M (-2.4%)
|
676.51M
est: 684.83M (-1.2%)
|
726.13M
est: 722.40M (+0.5%)
|
807.81M
est: 796.52M (+1.4%)
|
961.66M
est: 952.33M (+1.0%)
|
1.08B
est: 1.05B (+2.0%)
|
1.21B
est: 1.21B (+0.2%)
|
1.34B
est: 1.33B (+0.6%)
|
1.32B
est: 1.32B (-0.1%)
|
1.53B
est: 1.50B (+1.9%)
|
1.85B
est: 1.80B (+3.2%)
|
2.03B
est: 1.98B (+2.6%)
|
2.25B
est: 2.22B (+1.4%)
|
2.57B
2.53B – 2.63B
+15.9% YoY
|
2.91B
2.79B – 3.06B
+13.4% YoY
|
3.16B
3.14B – 3.19B
+8.6% YoY
|
3.22B
3.09B – 3.38B
+1.8% YoY
|
| EBITDA |
38.60M
est: 43.13M (-10.5%)
|
42.57M
est: 44.28M (-3.9%)
|
47.97M
est: 46.86M (+2.4%)
|
47.87M
est: 33.06M (+44.8%)
|
50.77M
est: 64.35M (-21.1%)
|
55.50M
est: 47.96M (+15.7%)
|
53.91M
est: 60.41M (-10.8%)
|
51.64M
est: 54.75M (-5.7%)
|
54.05M
est: 60.26M (-10.3%)
|
63.99M
est: 48.66M (+31.5%)
|
70.83M
est: 64.99M (+9.0%)
|
78.15M
est: 72.98M (+7.1%)
|
86.77M
est: 82.31M (+5.4%)
|
97.19M
est: 96.56M (+0.7%)
|
105.36M
est: 81.30M (+29.6%)
|
121.27M
est: 104.94M (+15.6%)
|
136.92M
est: 124.79M (+9.7%)
|
156.09M
est: 138.38M (+12.8%)
|
160.44M
est: 162.42M (-1.2%)
|
171.20M
est: 184.84M (-7.4%)
|
186.64M
est: 188.54M (-1.0%)
|
217.89M
est: 207.62M (+4.9%)
|
241.00M
est: 229.05M (+5.2%)
|
274.90M
est: 277.04M (-0.8%)
|
320.60M
est: 292.59M (+9.6%)
|
353.30M
est: 297.96M (+18.6%)
|
373.40M
est: 315.91M (+18.2%)
|
410.60M
est: 344.43M (+19.2%)
|
475.50M
est: 363.03M (+31.0%)
|
537.30M
est: 535.36M (+0.4%)
|
620.25M
611.56M – 635.28M
+15.9% YoY
|
703.18M
674.58M – 737.81M
+13.4% YoY
|
763.77M
758.32M – 769.21M
+8.6% YoY
|
777.70M
746.08M – 816.01M
+1.8% YoY
|
| EBIT |
34.20M
est: 32.88M (+4.0%)
|
37.57M
est: 38.53M (-2.5%)
|
37.05M
est: 41.11M (-9.9%)
|
42.12M
est: 28.33M (+48.7%)
|
35.45M
est: 53.63M (-33.9%)
|
48.48M
est: 38.73M (+25.2%)
|
46.54M
est: 50.82M (-8.4%)
|
44.09M
est: 44.76M (-1.5%)
|
37.68M
est: 47.44M (-20.6%)
|
54.68M
est: 36.29M (+50.7%)
|
59.49M
est: 50.06M (+18.8%)
|
65.01M
est: 63.25M (+2.8%)
|
70.89M
est: 71.84M (-1.3%)
|
76.85M
est: 80.98M (-5.1%)
|
84.42M
est: 75.55M (+11.7%)
|
99.54M
est: 94.81M (+5.0%)
|
123.20M
est: 112.97M (+9.1%)
|
124.19M
est: 121.84M (+1.9%)
|
129.22M
est: 127.77M (+1.1%)
|
137.13M
est: 153.25M (-10.5%)
|
148.11M
est: 152.79M (-3.1%)
|
168.44M
est: 169.21M (-0.5%)
|
187.20M
est: 184.25M (+1.6%)
|
219.00M
est: 209.02M (+4.8%)
|
235.90M
est: 239.73M (-1.6%)
|
263.00M
est: 236.59M (+11.2%)
|
312.70M
est: 250.83M (+24.7%)
|
309.00M
est: 273.49M (+13.0%)
|
369.90M
est: 288.26M (+28.3%)
|
417.00M
est: 408.17M (+2.2%)
|
472.89M
466.27M – 484.36M
+15.9% YoY
|
536.12M
514.32M – 562.53M
+13.4% YoY
|
582.32M
578.17M – 586.47M
+8.6% YoY
|
592.94M
568.83M – 622.15M
+1.8% YoY
|
| Net Income |
22.93M
est: 24.95M (-8.1%)
|
25.10M
est: 26.34M (-4.7%)
|
24.78M
est: 27.74M (-10.7%)
|
28.59M
est: 19.25M (+48.5%)
|
22.01M
est: 37.87M (-41.9%)
|
32.12M
est: 24.77M (+29.7%)
|
31.16M
est: 34.95M (-10.8%)
|
28.36M
est: 30.56M (-7.2%)
|
22.32M
est: 31.40M (-28.9%)
|
34.55M
est: 22.05M (+56.7%)
|
40.88M
est: 32.78M (+24.7%)
|
44.01M
est: 44.22M (-0.5%)
|
50.28M
est: 49.01M (+2.6%)
|
52.58M
est: 58.03M (-9.4%)
|
60.44M
est: 52.15M (+15.9%)
|
72.43M
est: 67.93M (+6.6%)
|
86.71M
est: 82.29M (+5.4%)
|
93.61M
est: 93.15M (+0.5%)
|
106.33M
est: 102.74M (+3.5%)
|
104.00M
est: 113.84M (-8.6%)
|
108.84M
est: 114.74M (-5.1%)
|
129.69M
est: 128.34M (+1.1%)
|
154.20M
est: 143.03M (+7.8%)
|
169.80M
est: 177.15M (-4.1%)
|
184.40M
est: 187.76M (-1.8%)
|
203.40M
est: 184.63M (+10.2%)
|
244.40M
est: 195.74M (+24.9%)
|
234.50M
est: 234.50M (+0.0%)
|
268.80M
est: 268.80M (+0.0%)
|
296.40M
est: 352.01M (-15.8%)
|
427.96M
420.32M – 435.60M
+21.6% YoY
|
485.89M
453.27M – 518.51M
+13.5% YoY
|
543.48M
513.95M – 573.00M
+11.9% YoY
|
566.77M
536.81M – 603.06M
+4.3% YoY
|
| SGA |
—
est: 57.06M (-100.0%)
|
—
est: 24.61M (-100.0%)
|
—
est: 26.41M (-100.0%)
|
—
est: 19.09M (-100.0%)
|
—
est: 33.10M (-100.0%)
|
—
est: 30.29M (-100.0%)
|
—
est: 33.03M (-100.0%)
|
—
est: 30.27M (-100.0%)
|
—
est: 38.26M (-100.0%)
|
36.34M
est: 37.18M (-2.3%)
|
7.07M
est: 45.71M (-84.5%)
|
8.45M
est: 47.14M (-82.1%)
|
9.12M
est: 57.70M (-84.2%)
|
10.73M
est: 68.29M (-84.3%)
|
9.62M
est: 59.69M (-83.9%)
|
11.07M
est: 67.26M (-83.5%)
|
11.81M
est: 76.04M (-84.5%)
|
203.14M
est: 78.97M (+157.2%)
|
225.30M
est: 117.95M (+91.0%)
|
246.14M
est: 211.29M (+16.5%)
|
275.44M
est: 249.55M (+10.4%)
|
342.70M
est: 293.93M (+16.6%)
|
382.90M
est: 338.50M (+13.1%)
|
382.70M
est: 394.05M (-2.9%)
|
432.10M
est: 421.52M (+2.5%)
|
412.50M
est: 386.77M (+6.7%)
|
484.70M
est: 410.06M (+18.2%)
|
614.50M
est: 447.09M (+37.4%)
|
636.10M
est: 471.24M (+35.0%)
|
724.10M
est: 708.30M (+2.2%)
|
820.61M
809.12M – 840.50M
+15.9% YoY
|
930.34M
892.50M – 976.16M
+13.4% YoY
|
1.01B
1.00B – 1.02B
+8.6% YoY
|
1.03B
987.09M – 1.08B
+1.8% YoY
|
| EPS |
0.13
est: 0.07 (+97.6%)
|
0.14
est: 0.07 (+86.7%)
|
0.14
est: 0.08 (+76.4%)
|
0.16
est: 0.08 (+90.9%)
|
0.12
est: 0.09 (+37.5%)
|
0.18
est: 0.09 (+94.6%)
|
0.17
est: 0.09 (+89.3%)
|
0.16
est: 0.08 (+108.2%)
|
0.12
est: 0.09 (+40.2%)
|
0.19
est: 0.10 (+99.6%)
|
0.22
est: 0.11 (+106.0%)
|
0.24
est: 0.12 (+94.0%)
|
0.27
est: 0.14 (+94.5%)
|
0.28
est: 0.15 (+80.8%)
|
0.32
est: 0.17 (+92.8%)
|
0.38
est: 0.21 (+83.8%)
|
0.46
est: 0.25 (+86.0%)
|
0.50
est: 0.27 (+88.2%)
|
0.28
est: 0.28 (-0.8%)
|
0.27
est: 0.31 (-12.4%)
|
0.29
est: 0.34 (-14.0%)
|
0.34
est: 0.40 (-14.2%)
|
0.41
est: 0.44 (-6.0%)
|
0.45
est: 0.50 (-10.6%)
|
0.49
est: 0.56 (-12.5%)
|
0.54
est: 0.56 (-3.9%)
|
0.65
est: 0.63 (+2.7%)
|
0.62
est: 0.75 (-17.3%)
|
0.71
est: 0.81 (-12.1%)
|
0.79
est: 0.92 (-14.3%)
|
1.13
1.11 – 1.15
+22.2% YoY
|
1.28
1.20 – 1.37
+13.9% YoY
|
1.43
1.36 – 1.51
+11.4% YoY
|
1.49
1.42 – 1.59
+4.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-06-11 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-10 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-09 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-08 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-05 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-04 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-03 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-02 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-06-01 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | B- | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
724.83M
OE per share TTM
1.91
Owner's Yield
4.90%
Maintenance CapEx ratio
4.39%
Maint CapEx / Avg PPE
12.3%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
65.7K
Shares Outstanding
377.70M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Marc Arthur Ronchetti | Group Chief Executive Officer, Member of Executive Board & Executive Director | 3M | male |
| Jennifer Ward | Group Talent, Culture & Communications Executive, Member of Executive Board and Executive Director | 1M | female |
| Carole Jean Cran | Chief Financial Officer, Member of Executive Board & Executive Director | 437.0K | female |
| Charlene Lim | Group General Counsel & Member of Executive Board | — | female |
| Charles King | Head of Investor Relations | — | male |
| Constance F. Baroudel | Chief Sustainability Officer, Sector Chief Executive Officer of Env. & Analysis and Member of Executive Board | — | female |
| Funmi Adegoke | Chief Executive Officer of Safety Sector & Member of Executive Board | — | female |
| Rob Lewis | Divisional Chief Executive of Environmental & Analysis Sector | — | male |
| Aldous Wong | President of Halma Asia Pacific, Adviser & Member of Executive Board | — | male |
| Steve Brown | Sector Chief Executive of Healthcare & Member of Executive Board | — | male |
| Bill Stoval | Chief Executive Officer of Divisional | — | male |
| Catherine E. Michel | Chief Technology Officer & Member of Executive Board | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HLMA.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
